The FATB antibody targets Fatty Acyl-ACP Thioesterase B (FATB), an enzyme critical for saturated fatty acid biosynthesis. FATB catalyzes the hydrolysis of fatty acyl-ACP thioesters to release free fatty acids, a key step in lipid metabolism. Research on FATB antibodies has provided insights into the enzyme's regulatory roles in plants and bacteria, particularly in fatty acid composition and stress responses .
Disruption of the FATB gene in Arabidopsis reduced saturated fatty acids by 50%, highlighting FATB's role in palmitic acid (16:0) synthesis. FATB antibodies confirmed the absence of the enzyme in knockout mutants, linking its activity to membrane integrity and seed viability .
In Vibrio anguillarum, FATB antibodies validated that iron deprivation upregulates fatB expression, essential for siderophore-mediated iron acquisition. This regulation is critical for bacterial survival under low-iron conditions .
| Property | Detail |
|---|---|
| Molecular Weight | 35 kDa |
| Localization | Membrane-associated |
| Regulatory Mechanism | Negative feedback by Fur protein |
| Source: Anti-FatB antibodies identified iron-dependent expression patterns . |
Crop Engineering: FATB antibodies aid in developing low-saturated-fat oilseed crops by validating gene-editing outcomes .
Bacterial Pathogenesis Studies: Used to track iron acquisition mechanisms in pathogenic bacteria, informing antimicrobial strategies .
While FATB antibodies are pivotal in lipid metabolism research, limitations include cross-reactivity risks with homologous thioesterases. Future work aims to engineer antibodies with enhanced specificity for industrial applications, such as biofuel production and synthetic biology .
How to validate FAT1 antibody specificity in Western blot?
What are common applications of FAT1 antibodies in cellular localization studies?
How to optimize immunofluorescence protocols for FAT1 detection?
How to resolve discrepancies in FAT1 expression data across studies?
What controls are essential in multicolor flow cytometry with FAT1 antibodies?
How to assess FAT1 antibody cross-reactivity with homologous proteins (e.g., FAT2/4)?
Why do some studies report FAT1 upregulation in obesity, while others show no change?